NIH Announces More Closed Sessions for Research Funding
Published Date: 7/13/2026
Notice
Summary
The Center for Scientific Review is holding several closed virtual meetings in early August 2026 to review and evaluate important grant applications. These meetings protect private info and trade secrets while deciding which scientific projects get funding. Researchers applying for grants in areas like HIV, heart disease, and brain disorders should note these dates as they impact funding decisions.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
NIH to Review Grants in Early August
The NIH Center for Scientific Review will hold closed virtual meetings on August 4, August 6, and August 6-7, 2026 to review and evaluate grant applications in areas such as HIV, cardiac biology, brain disease, infectious disease epidemiology, health technology, and vector-borne diseases. If you are a researcher with a pending NIH grant application in these topic areas, these meetings will be the events where funding decisions for those applications are evaluated.
Applicant Confidentiality Protected
The meetings will be closed to the public under 5 U.S.C. 552b(c)(4) and (c)(6) to protect confidential trade secrets, commercial property (including patentable material), and personal information about individuals associated with grant applications. This means proprietary scientific information and personal data in applicants' proposals will be kept private during the August 2026 review meetings.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-14003 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review and decide on important research grant applications. These meetings keep sensitive info private, protecting ideas and personal details. Scientists applying for grants and the research community will feel the impact as funding decisions get made on time.
2026-14001 — National Human Genome Research Institute; Notice of Meeting
The National Human Genome Research Institute is holding a public meeting on September 28-29, 2026, to share updates and review grant applications. Scientists, researchers, and anyone interested in human genetics can join in person or online. This meeting helps decide which projects get funding, so it impacts future research and innovation in genetics.
2026-13802 — Government Owned Invention Available for License: Generating Conditional and Reverse Conditional Loss-of-Function Alleles in Mouse Casq2
The National Institutes of Health is offering special mouse strains that help study a rare heart rhythm disorder called CPVT. These mice let scientists explore how a key heart gene works and test new gene therapies. Researchers interested in this tool can access it now—no patents, just pure science ready to speed up discoveries!
2026-13612 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review and decide on important health research grant applications. These meetings keep sensitive info private to protect personal and commercial secrets. Researchers applying for grants and the public can expect no changes in funding timing or amounts, just careful, confidential reviews.
2026-13480 — Government Owned Invention Available for License: A Conserved Viral Peptide for Use in Cancer Immunotherapy
The National Cancer Institute has created a special viral peptide that could help prevent and treat a serious liver cancer called HCC. This new discovery might lead to a vaccine or therapy that boosts the immune system to fight cancer better. Researchers and companies interested in developing this treatment can now license the technology, opening doors for faster progress and potential health benefits worldwide.
2026-13479 — Government Owned Invention Available for License: Chimeric VLP Vaccines To Prevent HTLV-1 Infection
The National Cancer Institute has created a new vaccine to stop HTLV-1, a virus that can cause serious diseases like leukemia. Right now, no vaccine exists, so this invention could protect millions, especially in underserved areas. They’re looking for partners to help develop and license this promising vaccine, which could save lives and reduce healthcare costs in the near future.
Previous / Next Documents
Previous: 2026-13997 — Agency Information Collection Activities; Comment Request on U.S. Information Returns and Related Forms, Schedules, Attachments, and Published Guidance
The IRS wants your thoughts on their tax forms and info collection to make sure they’re useful and not too tricky. If you or your business deals with U.S. tax forms, this is your chance to help shape them before September 11, 2026. The goal? Keep things clear, easy, and fair—saving time and maybe even money down the road!
Next: 2026-14001 — National Human Genome Research Institute; Notice of Meeting
The National Human Genome Research Institute is holding a public meeting on September 28-29, 2026, to share updates and review grant applications. Scientists, researchers, and anyone interested in human genetics can join in person or online. This meeting helps decide which projects get funding, so it impacts future research and innovation in genetics.